Parallax Volatility Advisers, L.P. Eagle Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$51.25 - $76.62 $51,301 - $76,696	-1,001 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $80,430 - $103,098	-1,542 Reduced 60.64%	1,001 $53,000
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $121,272 - $148,827	2,445 Added 2494.9%	2,543 $136,000
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $4,568 - $5,915	98	98 $6,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.